POAI Predictive Oncology Inc Quick Ratio

The Predictive Oncology (POAI) price chart on the GURU.Markets platform demonstrates a current coefficient of 0.01, while the business minimizes risks through partnerships with various pharmaceutical companies. The model relies on clinical data sets to simulate the impact of drugs on neoplasms. Leveraging unique software and data volume, the developer effectively monetizes its analytical services by engaging with the market's largest players.

For an investor in the high-tech AI oncology sector, Predictive Oncology (POAI) must possess the critical ability to fund expensive biobanks without external support. This metric assesses solvency via the sum of cash and accounts receivable, excluding illiquid inventories, which reflects the business's real margin of safety. By analyzing fluctuations in the quick ratio, the market determines the balance between the issuer's financial viability and capital efficiency.